New phase 2 clinical trial for patients with locally advanced or metastatic sarcoma

TAK-228 is an mTOR inhibitor that prevents growth of cancer cells and has been shown to prevent tumor growth in animals. Therefore, the doctors now want to test if this drug can prevent tumor growth in patients with soft tissue sarcomas.

(RSS generated with FetchRss)